Stemcell Holdings Inc (STMM)
0.06
0.00 (0.00%)
USD |
OTCM |
Apr 30, 16:00
Stemcell Holdings Gross Profit Margin (Quarterly)
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
Date | Value |
---|---|
September 30, 2018 | 78.08% |
June 30, 2018 | 75.50% |
March 31, 2018 | 78.04% |
December 31, 2017 | 77.09% |
September 30, 2017 | 80.96% |
Date | Value |
---|---|
June 30, 2017 | 82.16% |
March 31, 2017 | 83.30% |
December 31, 2016 | 84.42% |
September 30, 2016 | 90.26% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit Margin (Quarterly) Benchmarks
AIM ImmunoTech Inc | 81.54% |
Perspective Therapeutics Inc | -- |
Protalix BioTherapeutics Inc | 15.54% |
Electromed Inc | 77.03% |
Armata Pharmaceuticals Inc | -- |